← Scroll for more →
Omeros Corp (OMER)
Pharmaceutical Preparations
Latest Price
$18.44
TTM P/E
10.66
Normalized P/E
62.12
TTM Div Yield
--
Fwd Div Yield
--
Book Value
0.33
P/B Ratio
56.50
Institutional Ownership
52.7% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 6.04M | $57.0M | 8.39% | +735.0K | 2026-06-30 |
| Ingalls & Snyder LLC | 3.66M | $34.0M | 5.08% | +100.1K | 2026-06-30 |
| UBS Group AG | 3.15M | $29.0M | 4.37% | +807.7K | 2026-06-30 |
| Vanguard Capital Management LLC | 3.07M | $29.0M | 4.26% | +88.8K | 2026-06-30 |
| State Street Corp | 2.32M | $22.0M | 3.22% | +400.3K | 2026-06-30 |
| Geode Capital Management, LLC | 1.91M | $18.0M | 2.66% | +162.1K | 2026-06-30 |
| Stifel Financial Corp | 1.84M | $17.0M | 2.55% | +5.3K | 2026-06-30 |
| Vanguard Portfolio Management LLC | 962.8K | $9.0M | 1.34% | +244.2K | 2026-06-30 |
| Citadel Advisors LLC | 830.0K | $7.0M | 1.15% | +115.8K | 2026-06-30 |
| Invesco Ltd. | 751.8K | $7.0M | 1.04% | +571.1K | 2026-06-30 |